AMO1细胞

AMO-1、AMO-1、AMO-1细胞、AMO-1细胞、AMO-1人骨髓浆细胞瘤

Cell line name AMO1

Synonyms AMo1; AMO-1

Accession CVCL_1806

Resource Identification Initiative To cite this cell line use: AMO1 (RRID:CVCL_1806)

Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

Part of: COSMIC cell lines project.

Part of: MD Anderson Cell Lines Project.

Population: Japanese.

Characteristics: Produces IgA kappa.

Doubling time: ~24 hours (PubMed=8426482); ~70-90 hours (DSMZ=ACC-538).

Microsatellite instability: Stable (MSS) (Sanger).

Omics: Array-based CGH.

Omics: Deep exome analysis.

Omics: Deep quantitative proteome analysis.

Omics: DNA methylation analysis.

Omics: Protein expression by reverse-phase protein arrays.

Omics: SNP array analysis.

Omics: Transcriptome analysis by microarray.

Omics: Transcriptome analysis by RNAseq.

Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.

Derived from site: In situ; Ascites; UBERON=UBERON_0007795.

Cell type: B-cell; CL=CL_0000236.

PubMed=8426482

Shimizu S., Takiguchi T., Fukutoku M., Yoshioka R., Hirose Y., Fukuhara S., Ohno H., Isobe Y., Konda S.

Establishment of a CD4-positive plasmacytoma cell line (AMO1).

Leukemia 7:274-280(1993)

 

PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x; PMCID=PMC5921886

Takizawa J., Suzuki R., Kuroda H., Utsunomiya A., Kagami Y., Joh T., Aizawa Y., Ueda R., Seto M.

Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.

Jpn. J. Cancer Res. 89:712-718(1998)

 

DOI=10.1007/0-306-46877-8_4

Jernberg-Wiklund H., Nilsson K.

Multiple myeloma cell lines.

(In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000)

 

PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2

Drexler H.G., Matsuo Y.

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.

Leuk. Res. 24:681-703(2000)

 

DOI=10.1016/B978-0-12-221970-2.50457-5

Drexler H.G.

The leukemia-lymphoma cell line factsbook.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

 

PubMed=11429052; DOI=10.1111/j.1349-7006.2001.tb01142.x; PMCID=PMC5926752

Hanamura I., Iida S., Akano Y., Hayami Y., Kato M., Miura K., Harada S., Banno S., Wakita A., Kiyoi H., Naoe T., Shimizu S., Sonta S.-i., Nitta M., Taniwaki M., Ueda R.

Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.

Jpn. J. Cancer Res. 92:638-644(2001)

 

PubMed=12886255; DOI=10.1038/sj.leu.2403026

Hayami Y., Iida S., Nakazawa N., Hanamura I., Kato M., Komatsu H., Miura I., Dave B.J., Sanger W.G., Lim B., Taniwaki M., Ueda R.

Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma.

Leukemia 17:1650-1657(2003)

 

PubMed=15215163; DOI=10.1016/S0002-9440(10)63276-2; PMCID=PMC1618545

Inoue J., Otsuki T., Hirasawa A., Imoto I., Matsuo Y., Shimizu S., Taniwaki M., Inazawa J.

Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Am. J. Pathol. 165:71-81(2004)

 

PubMed=17171682; DOI=10.1002/gcc.20404

Lombardi L., Poretti G., Mattioli M., Fabris S., Agnelli L., Bicciato S., Kwee I., Rinaldi A., Ronchetti D., Verdelli D., Lambertenghi-Deliliers G., Bertoni F., Neri A.

Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.

Genes Chromosomes Cancer 46:226-238(2007)

 

PubMed=18700954; DOI=10.1186/1755-8794-1-37; PMCID=PMC2531129

Ronchetti D., Lionetti M., Mosca L., Agnelli L., Andronache A., Fabris S., Lambertenghi-Deliliers G., Neri A.

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma.

BMC Med. Genomics 1:37.1-37.9(2008)

 

PubMed=19306352; DOI=10.1002/gcc.20660

Lionetti M., Agnelli L., Mosca L., Fabris S., Andronache A., Todoerti K., Ronchetti D., Lambertenghi-Deliliers G., Neri A.

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

Genes Chromosomes Cancer 48:521-531(2009)

 

PubMed=21173094; DOI=10.3324/haematol.2010.033456; PMCID=PMC3069235

Moreaux J., Klein B., Bataille R., Descamps G., Maiga S., Hose D., Goldschmidt H., Jauch A., Reme T., Jourdan M., Amiot M., Pellat-Deceunynck C.

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines.

Haematologica 96:574-582(2011)

 

PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027

Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Nature 483:603-607(2012)